Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SPX-1009 leads to suppression of melanoma cells

May 27, 2021

Bioardis patents CD73 inhibitors

May 27, 2021

Hangzhou Bangshun Pharmaceutical decribes new RET inhibitors

May 27, 2021

Tango Therapeutics presents new PRMT5 inhibitors

May 27, 2021

New G12C mutant KRAS inhibitors discovered at Beijing Jacobio Pharmaceuticals

May 27, 2021

Moleculin receives clearance to initiate phase Ib/II study of annamycin for STS lung metastases

May 26, 2021

New CD38 inhibitors discovered at Mitobridge

May 26, 2021

Janssen Biotech discloses new dihydroorotate dehydrogenase inhibitors

May 26, 2021

Data reported from CRPC cohort 6 of COSMIC-021 study of cabozantinib plus atezolizumab

May 26, 2021

Preclinical data support clinical evaluation of iOnctura's autotaxin inhibitor IOA-289

May 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...